As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes
If you are building out a full routine, the Liposomal Vitamin C formula can be a natural companion
Impact of nodal status and tumor burden in sentinel lymph nodes on the clinical outcomes of cancer patients
Emergency interventions include giving fluids to replace lost blood and prevent shock
I have my clients and readers, family members, my own body, wonderful colleagues, and access to the latest medical research to help
The NAD+ layer fits where the goal is maximum skin remodeling, where GLP-1 use or caloric deficit is present, where fatigue is part of the picture, or where progress stalls after a clean first month
